Title of article
Minimum Requirements for Reporting Fecal Microbiota Transplant Trial
Author/Authors
Moossavi، Shirin نويسنده , , Bishehsari، Faraz نويسنده , , Ansari، Reza نويسنده , , Vahedi، Homayoon نويسنده , , Nasseri-Moghaddam، Siavosh نويسنده , , Merat، Shahin نويسنده , , Sobhani، Iradj نويسنده , , Keshavarzian، Ali نويسنده , , Malekzadeh، Reza نويسنده ,
Issue Information
فصلنامه با شماره پیاپی سال 2015
Pages
4
From page
177
To page
180
Abstract
Fecal microbiota transplant (FMT) research trials are growing in diverse intestinal and extraintestinal conditions that are thought to be either caused or correlated with gut microbiota dysbiosis. Although, the mechanism by which the microbiota results in disease initiation or progression is not fully understood, it is speculated that restoring the symbiosis by FMT could have therapeutic benefits.
Keywords
Dysbiosis , Fecal Microbiota , Therapeutic benefits
Journal title
Middle East Journal of Digestive Diseases(MEJDD)
Serial Year
2015
Journal title
Middle East Journal of Digestive Diseases(MEJDD)
Record number
2403436
Link To Document